InChI
1S/C2H6OS/c1-4(2)3/h1-2H3/i1D3,2D3
InChI key
IAZDPXIOMUYVGZ-WFGJKAKNSA-N
SMILES string
[2H]C([2H])([2H])S(=O)C([2H])([2H])[2H]
vapor pressure
0.42 mmHg ( 20 °C)
isotopic purity
99.9 atom % D
assay
99% (CP)
autoignition temp.
573 °F
contains
0.07 wt. % TSP-d4
expl. lim.
42 %
refractive index
n20/D 1.476 (lit.)
bp
189 °C (lit.)
mp
20.2 °C (lit.)
density
1.190 g/mL at 25 °C (lit.)
mass shift
M+6
正在寻找类似产品? 访问 产品对比指南
General description
Dimethyl sulfoxide-d6 (DMSO-d6) is a deuterated NMR solvent containing 0.07wt.% TSP-d4 (3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt). It undergoes photodissociation to generate CD3 radical photoproducts, which have been analyzed by infrared diode laserabsorption spectroscopy. Dissociation dynamics of DMSO-d6 at 193nm was examined using photo fragment translational spectroscopy method.
Application
Dimethyl sulfoxide-d6 may be used as NMR solvent for 1H and 13C NMR experiments.
Packaging
This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
190.4 °F
flash_point_c
88 °C
P Bustillo Trueba et al.
Journal of chromatography. A, 1604, 460467-460467 (2019-08-28)
This paper describes the method validation for the simultaneous determination of seven cysteinylated aldehydes, i.e. 2-substituted 1,3-thiazolidines-4-carboxylic acids, using ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS). Authentic reference compounds were first synthesized for identification and quantification purposes. Moreover, nuclear magnetic resonance (1H
Solution forms of an antitumor cyclic hexapeptide, RA-VII in dimethyl sulfoxide-d6 from nuclear magnetic resonance studies.
Itokawa H, et al.
Chemical & Pharmaceutical Bulletin, 40(4), 1050-1052 (1992)
Diode laser measurements of CD3 quantum yields and internal energy for the dissociation of dimethyl sulfoxide-d6.
Rudolph RN, et al.
J. Chem. Phys. , 106(4), 1346-1352 (1997)
Luís Novo et al.
Molecular pharmaceutics, 12(1), 150-161 (2014-11-11)
The applicability of small interfering RNA (siRNA) in future therapies depends on the availability of safe and efficient carrier systems. Ideally, siRNA delivery requires a system that is stable in the circulation but upon specific uptake into target cells can
Xue Wang et al.
Scientific reports, 5, 16127-16127 (2015-11-05)
The human β-amyloid (Aβ) cleaving enzyme (BACE-1) is a target for Alzheimer's disease (AD) treatments. This study was conducted to determine if acacetin extracted from the whole Agastache rugosa plant had anti-BACE-1 and behavioral activities in Drosophila melanogaster AD models
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持